ArticleBMC cancer2021

Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone.

Zhenyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.